Caveolin-1, which is a potential target for MSC therapy, showed a significant suppression effect on hepatic stellate cells
Real-world anecdotal efficacy for tendon repair, inflammation reduction, and gut health support
For type 2 diabetes, NICE recommends GLP-1 agonists when other treatments haven't achieved target HbA1c levels, with specific consideration for cardiovascular and renal risk factors according to NICE guideline NG28
Benkhoucha M, Santiago-Raber M-L, Schneiter G, Chofflon M, Funakoshi H, Nakamura T, Lalive PH
For a single discrete tendon injury with an identifiable injection site, BPC-157 is typically more effective because it activates the fibroblasts that produce collagen directly at the repair location
Michael Galitzer: More than anything, the biggest obstacle in peoples health is being in emotional distress